These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36748921)

  • 21. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.
    Federici C; Fornaro G; Roehr CC
    Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Outcomes of Less Invasive Surfactant Administration in Prematurely Born Infants in the Delivery Suite and the Neonatal Unit.
    Shetty S; Tolentino D; Kulkarni A; Duffy D; Greenough A
    Am J Perinatol; 2024 May; 41(S 01):e2674-e2678. PubMed ID: 37500076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Less invasive surfactant administration: best practices and unanswered questions.
    Herting E; Härtel C; Göpel W
    Curr Opin Pediatr; 2020 Apr; 32(2):228-234. PubMed ID: 32068592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of LISA versus InSurE: A single center experience.
    Queliz T; Perez JA; Corrigan MJ
    J Neonatal Perinatal Med; 2021; 14(4):503-509. PubMed ID: 33646183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory distress syndrome in preterm infants: possible impact of surfactant application techniques.
    Krajewski P; Pomianek T; Truszkowski K; Wieckowska K; Gorska M; Wielgos M
    Ginekol Pol; 2022; 93(9):750-755. PubMed ID: 35106747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
    Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
    J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.
    Härtel C; Herting E; Humberg A; Hanke K; Mehler K; Keller T; Mauer I; Frieauff E; Meyer S; Thome UH; Wieg C; Schmidtke S; Kribs A; Göpel W;
    JAMA Netw Open; 2022 Aug; 5(8):e2225810. PubMed ID: 35943742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
    Network of Northwest Neonatal Professional Collaboration Group
    Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and safety of inhalation of pulmonary surfactant using vibrating mesh nebulizers combined with nasal continuous positive airway pressure in the treatment of neonatal respiratory distress syndrome].
    Gao Y; Chen X; Zhang Z; Qu S; Sang X; Wu Y; Zhou R; Peng W; Chen Y; Wang Y; Zhuo F; Chen L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):80-84. PubMed ID: 35307066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thin-catheter Surfactant Application for Respiratory Distress Syndrome in Spontaneously Breathing Preterm Infants: A Meta-analysis of Randomized Clinical Trials.
    Kesler H; Lohmeier K; Hoehn T; Kribs A; Peinemann F
    Curr Pediatr Rev; 2022; 18(4):286-300. PubMed ID: 35379135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of less invasive surfactant administration using video laryngoscopy in extremely preterm infants.
    Baczynski M; Deekonda V; Hamilton L; Lindsay B; Ye XY; Jain A
    Pediatr Res; 2023 Mar; 93(4):990-995. PubMed ID: 35854087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants.
    Göpel W; Kribs A; Härtel C; Avenarius S; Teig N; Groneck P; Olbertz D; Roll C; Vochem M; Weller U; von der Wense A; Wieg C; Wintgens J; Preuss M; Ziegler A; Roth B; Herting E;
    Acta Paediatr; 2015 Mar; 104(3):241-6. PubMed ID: 25474712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience of less invasive surfactant administration with a 5F infant feeding tube in a tertiary center of low- and middle-income countries.
    Sk MH; Saha B
    Pediatr Int; 2023; 65(1):e15668. PubMed ID: 38009628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.